| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,404 | 11,351 | 8,899 | 14,521 | | Cost of Revenue | 5,586 | 4,570 | 3,179 | 717 | | | Gross Profit | 8,818 | 6,782 | 5,720 | 13,804 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 990 | 862 | 702 | 808 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 666 | 654 | 636 | 69 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 8,908 | 5,265 | 4,382 | 12,927 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11 | 4 | 14 | (67) | | Earnings Before Interest And Taxes | 7,182 | 5,269 | 4,396 | 12,860 | | Interest Expense | 307 | 298 | 292 | 852 | | Income Before Tax | 6,875 | 4,970 | 4,104 | 12,009 | | Income Tax Expense | 2,186 | 1,668 | 1,420 | 3,406 | | Minority Interest | (636) | (898) |
-
| (1,020) | | | | Net Income From Continuing Ops | 4,053 | 2,405 | 2,684 | 7,583 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,053 | 2,405 | 2,684 | 7,583 | | Preferred Stock And Other Adjustments |
-
| 413 | (413) |
-
| | | Net Income Applicable To Common Shares | $4,053 | $2,818 | $2,271 | $7,583 |
|
0.51% Nasdaq 
Income Statement
